Windsor Creek Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Windsor Creek Advisors’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.31M	Buy	11,014 +7,000	+174%	+$844K	0.4%	62
2021 Q3	$505K	Sell	4,014 -1,000	-20%	-$129K	0.14%	102
2021 Q2	$679K	Buy	5,014 +3,000	+149%	+$394K	0.18%	120
2021 Q1	$273K	Hold	2,014	–	–	0.07%	151
2020 Q4	$284K	Sell	2,014 -1,997	-50%	-$256K	0.07%	156
2020 Q3	$447K	Sell	4,011 -2,999	-43%	-$336K	0.13%	117
2020 Q2	$785K	Sell	7,010 -12,501	-64%	-$1.23M	0.26%	75
2020 Q1	$1.51M	Sell	19,511 -15,000	-43%	-$1.33M	0.54%	42
2019 Q4	$3.28K	Buy	34,511 +4,000	+13%	+$346K	0.87%	23
2019 Q3	$2.33M	Buy	30,511 +2,502	+9%	+$208K	0.57%	37
2019 Q2	$2.46M	Sell	28,009 -6,000	-18%	-$512K	0.67%	30
2019 Q1	$3.08M	Sell	34,009 -3,702	-10%	-$315K	0.83%	19
2018 Q4	$2.82M	Buy	+37,711	New	+$3.04M	0.89%	28

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Windsor Creek Advisors's XBI Position: Q4 2021 in Review

Windsor Creek Advisors increased its State Street SPDR S&P Biotech ETF (XBI) stake by 174% in Q4 2021, buying an estimated $844K and bringing the position to 11,014 shares worth $1.31M. The position accounts for 0.4% of the portfolio, ranked #62.

Windsor Creek Advisors first reported a position in XBI in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.08M in Q1 2019. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

Windsor Creek Advisors held 11,014 shares of State Street SPDR S&P Biotech ETF worth $1.31M as of Q4 2021.
Windsor Creek Advisors bought 7,000 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $844K.
State Street SPDR S&P Biotech ETF made up 0.4% of Windsor Creek Advisors's portfolio in Q4 2021, its #62 holding.
Windsor Creek Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q4 2018 and has held it in 13 quarters since.
Windsor Creek Advisors's State Street SPDR S&P Biotech ETF position peaked at $3.08M in Q1 2019.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on Windsor Creek Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.